Clinical trialCLINICALTRIALSApr 8
Researchers completed a small study testing whether a drug called Adalimumab (brand name Humira) could help people with Netherton syndrome, a rare skin condition that causes severe itching, rashes, and inflammation. Eleven patients received the drug for 3 months and were then followed for another 3 months to see if it was safe and if it improved their symptoms, including pain and itching.
WHY IT MATTERSThis completed trial provides evidence about whether Humira—a drug already used for other inflammatory conditions—could be repurposed to treat Netherton syndrome, which currently has very limited treatment options.
Clinical trialUNITERAREApr 5
Researchers are looking for people with Down syndrome (Trisomy 21) to join a study about how their immune system works differently and ages over time. Some participants will have had their thymus gland removed, while others won't have, so scientists can compare how this affects immune health. The study will help doctors understand why people with Down syndrome often get more infections and have other immune-related health problems.
WHY IT MATTERSThis trial is now recruiting people with Down syndrome to help researchers understand immune system problems that affect this population — findings could lead to better treatments for infections and other immune conditions common in Trisomy 21.
ResearchPUBMEDMar 26
Shulman syndrome, also called eosinophilic fasciitis, is a rare disease where the tissue layers under the skin become thick and painful. This case describes a man whose condition started after minor injuries and spread throughout his body. Doctors confirmed the diagnosis using a deep skin biopsy and special imaging scans. This article helps doctors recognize unusual presentations of this rare disease.
WHY IT MATTERSThis case report documents an atypical presentation of Shulman syndrome that initially mimicked lymphedema on imaging, helping clinicians recognize and correctly diagnose this rare condition earlier to avoid delayed treatment.
ResearchCLINICALTRIALSMar 26
Researchers in Italy completed a registry study where they collected information from 82 patients with Angelman Syndrome. A registry is like a database that stores health information to help doctors and scientists learn more about a disease. No patients received any experimental treatment—they just shared their medical information, which is kept private and secure.
WHY IT MATTERSThis completed Italian registry provides real-world data on Angelman Syndrome patients that researchers can use to design better treatments and understand how the condition affects people over time.
Clinical trialCLINICALTRIALSMar 26
Researchers are looking for pregnant women or women planning to get pregnant who have rare blood vessel diseases like Hereditary Hemorrhagic Telangiectasia, Marfan syndrome, lymphedema, or arteriovenous malformations. This study will track their pregnancies to understand what complications might happen for the mother and baby, since doctors don't have good information about this yet.
WHY IT MATTERSThis is the first large study to prospectively track pregnancy outcomes in women with these rare vascular diseases, filling a critical gap in medical knowledge that could directly improve care and safety for pregnant patients with these conditions.